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Abstract 26 
Clostridium difficile is a major cause of antibiotic induced diarrhoea worldwide, 27 
responsible for significant annual mortalities and represents a considerable economic 28 
burden on healthcare systems. The two main C. difficile virulence factors are toxins A and B. 29 
Isogenic toxin B mutants of two independently isolated erythromycin-sensitive derivatives 30 
(630E and 630Δerm) of strain 630 were previously shown to exhibit substantively different 31 
phenotypes.  Compared to 630, strain 630E and its progeny grow slower, achieve lower final 32 
cell densities, exhibit a reduced capacity for spore-formation, produce lower levels of toxin 33 
and are less virulent in the hamster infection model. By the same measures, strain 630Δerm 34 
and its derivatives more closely mirror the behaviour of 630. Genome sequencing revealed 35 
that 630Δerm had acquired seven unique Single Nucleotide Polymorphisms (SNPs) 36 
compared to 630 and 630E, while 630E had nine SNPs and a DNA inversion not found in the 37 
other two strains.  The relatively large number of mutations meant that the identification of 38 
those responsible for the altered properties of 630E was not possible, despite the 39 
restoration of three mutations to wildtype by allelic exchange and comparative RNAseq 40 
analysis of all three strains. The latter analysis revealed large differences in gene expression 41 
between the three strains, explaining in part why no single SNP could restore the phenotypic 42 
differences. Our findings suggest that strain 630∆erm should be favoured over 630E as a 43 
surrogate for 630 in genetic-based studies.  They also underline the importance of effective 44 
strain curation and the need to genome re-sequence master seed banks wherever possible.   45 
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Introduction 46 
 47 
Clostridium difficile is a Gram-positive, anaerobic spore-forming bacterium capable of 48 
causing a range of diseases from mild diarrhoea to potentially fatal toxic 49 
pseudomembranous colitis. The toxigenic effects of C. difficile are caused by the activities of 50 
two large, glucosylating toxins. The two toxins are 308kDa (toxin A) and 270kDa (toxin B) in 51 
size 1-3 and are encoded by the chromosomally located genes tcdA and tcdB, respectively. 52 
Both are cytopathic to cultured cells due to disruption of the cytoskeleton, although TcdB is 53 
thought to be up to 1000-times more potent.1 Historically, toxin A was regarded as the main 54 
causative agent of the symptoms of C. difficile infection (CDI). Pivotal data was provided by 55 
Lyerly et al.4 who were only able to detect disease when hamsters were subject to 56 
intragastric challenge with purified TcdA alone and not with TcdB. The latter could, however, 57 
cause disease symptoms if prior damage to the mucosa had been inflicted by co-58 
administration of sub-lethal concentrations of toxin A. Furthermore, co-administration of 59 
both toxins led to more severe disease symptoms. To accommodate these data, it was 60 
generally accepted that both toxins acted in concert to bring about disease symptoms, with 61 
toxin A leading to the initial damage to the colon allowing the subsequent access of the more 62 
potent toxin B. 63 
During the 1990’s C. difficile strains were isolated from symptomatic patients that only 64 
produced toxin B (A-B+)5, 6. These findings suggested that toxin B, at least in certain strains, 65 
is capable of causing disease without the help of toxin A. It has been reported since that 66 
toxin B, in A-B+ strains, is modified and seems to be an evolutionary hybrid of C. difficile 67 
toxin B and Clostridium sordellii lethal toxin.7 68 
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With the development of genetic systems, assumptions of the relative importance of 69 
the two toxins could be tested through the creation, and in vivo assay, of isogenic mutants 70 
in which production of either toxin had been ablated. Initial findings made by Lyras et al.8 71 
appeared to turn the perceived view on its head, through the demonstration that a tcdA 72 
mutant producing TcdB alone (A-B+) was capable of causing disease in the hamster model 73 
while a tcdB mutant producing only TcdA (A+B-) did not.  These data were, however, almost 74 
immediately questioned by a second study conducted in the Minton laboratory 9 showing 75 
that both tcdA and tcdB C. difficile mutants, and therefore TcdA and TcdB alone, were 76 
independently capable of causing disease. Interestingly, a strain has recently10 beren 77 
isolated from a clinical case of CDI, that only produces TcdA (A+B-) 78 
The possible reasons for the observed difference in outcomes of the two studies have 79 
been discussed previously. 11 Both studies agree on the virulence potential of toxin B, but 80 
uncertainties remain about the different outcomes concerning the effects of toxin A. In the 81 
work presented here, we have hence focused on comparisons of the parental strains and 82 
the strains only producing toxin A (A+B-). In essence, both sets of mutants were generated 83 
by insertional inactivation of the toxin genes of the C. difficile strain 630 12 and, once created, 84 
were tested in the hamster infection model. However, in order to implement the available 85 
gene tools in strain 630 (at the time the only strain for which a genome sequence was 86 
available), it was necessary to first isolate a variant that had become sensitive to 87 
erythromycin, thereby allowing the use of an ermB gene as a selective, genetic marker. Both 88 
studies used such an erythromycin-sensitive derivative of strain 630, but they were 89 
independently isolated.  In our study (Minton group), 9 we used the strain 630Δerm, isolated 90 
in the Mullany laboratory (UCL, London, UK) after 30 repeated subcultures of strain 630 in 91 
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non-selective media. 13 In parallel, the Rood laboratory (Monash, Australia) independently 92 
isolated the erythromycin sensitive strain JIR8094 (also referred to as 630E), 14 through an 93 
undisclosed number of subcultures of strain 630 in non-selective media. Both strains are 94 
reported to possess the same specific deletion of ermB. 13, 14 95 
We have previously hypothesised 11 that the different outcomes of the two studies 8, 9 96 
are a direct consequence of the use of the two, independently isolated erythromycin-97 
sensitive strains, 630Δerm and 630E. We suggested that during repeated subculture, 98 
ancillary mutations arose which impacted on the virulence potential of one or other of the 99 
two strains in the presence of different toxin gene alleles. In the current piece of work, we 100 
have set out to test this hypothesis. We have undertaken side-by-side comparisons of 101 
630Δerm and 630E, and the A+B- mutant derivatives, in a variety of assays to establish 102 
phenotypic differences. In parallel, we have determined the genome sequences of the 103 
various strains used in the two studies. 8, 9 Then, we have used our newly developed allelic 104 
exchange methodologies 15 to correct a number of SNPs in strain 630E back to wild-type and 105 
assessed the consequences. Furthermore we have performed RNAseq experiments 106 
comparing the transcriptome of 630, 630Δerm and 630E at three different time points. The 107 
RNA data were related to the whole genome data to draw our final conclusions. 108 
 109 
Results 110 
Generation of a ClosTron insertion in tcdB of 630E 111 
Although considered unlikely, the possibility existed that mutants made by the insertion 112 
of a plasmid element carrying ermB 14 might behave differently to an equivalent mutant 113 
made by the insertion of a group II intron incorporating ermB. 16 Our initial step was, 114 
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therefore, to create a tcdB mutant of strain 630E using ClosTron technology. Accordingly, 115 
the ClosTron plasmid pMTL007C-E2::Cdi-tcdB-1511a that had previously been used to 116 
generate strain 630∆erm A+B- 9 was used to create an equivalent mutant in strain 630E as 117 
described. 9 The resulting mutant, 630E A+B-CT, was verified by PCR, Sanger sequencing and 118 
shown by Southern blot to carry a single group II intron insertion (Fig. S1A). Parental strains, 119 
original A+B- mutants and the newly obtained mutant were tested for production of toxin A 120 
in a Western blot (Fig. S1B). As expected all strains produced toxin A. 121 
 122 
Phenotypic characterisation of strains 123 
In order to establish whether all strains were phenotypically identical a range of assays 124 
were performed, comparing growth, motility and spore properties. An analysis of growth 125 
rates using the procedure described in Materials and Methods showed that strain 630∆erm 126 
and derivatives grew to the highest optical density, closely followed by strain 630 and 630E, 127 
and derivatives thereof (Fig. 1A and 1B). The data clearly demonstrated that strain 630∆erm 128 
and its 630∆erm A+B- derivative had relatively higher growth rates and achieved higher 129 
optical densities (p < 0.0001, unpaired t-test at 24 h) than strain 630E and its derivatives, 130 
with strain 630E A+B-CT growing the least (Fig. 1B). It was also apparent, shown by plate 131 
motility assay (Fig. 2), that strains 630 and 630∆erm were motile, while 630E was not. Only 132 
630 and 630∆erm, but not 630E, form pseudopod-like structures, which are characteristic 133 
for swarming motility in bacteria.   134 
Following the protocols of Burns et al, 17 comparative differences in the numbers of 135 
colony forming units (CFUs) obtained following heat shock were assessed between the 136 
strains, as a crude estimate of spore formation. 18 On this basis, strains 630∆erm and 137 
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630∆erm A+B- produced a greater numbers of spores than 630E and its derivatives, which 138 
failed to produce any spores until 72 h. The total number of CFU/mL at this time point was 139 
103 times fewer than that obtained with 630∆erm or 630∆erm A+B- (Fig. 3A). Interestingly 140 
parental strain 630 produced very few spores before 72 h, but spore counts increased from 141 
72 h onwards and reached similar levels to strains 630∆erm and 630∆erm A+B- by the end 142 
of the experiment. The reduction in spore formation may in part be due to the observed 143 
reduction in OD as the 630E strains enter stationary phase, which might also explain their 144 
predilection to flocculate. Indeed comparing percentage sporulation (relative to vegetative 145 
cell count), confirmed the observation that 630∆erm and 630∆erm A+B- have a higher 146 
sporulation frequency than both 630E (and derivatives) and strain 630. 147 
The germination of the 630E strains was also comparatively reduced and did not reach 148 
the same level as that of 630∆erm and its progeny. At the last time point (240 min) strains 149 
630E and 630E A+B- reach the same level of CFU/ml as strain 630. The observed delay could 150 
be due to the previously observed reduced cell growth of the 630E strains (Fig. 3B).   151 
 152 
Toxin Production  153 
Measurements of the amounts of toxin being produced by 630E and 630∆erm and their 154 
derivatives were undertaken using both the C. DIFFICILE TOX A/B II™ ELISA assay kit from 155 
TechLab, measuring toxin A and B, and kits from TGCbiomics, specifically measuring either 156 
only toxin A or only toxin B. The results of the 72 h time point are shown in Fig. 4.  157 
As shown in Fig. 4A, toxin production of 630, 630∆erm or 630∆erm A+B- clustered 158 
together, as did toxin production of 630E, 630E A+B- or 630E A+B- CT with the latter three 159 
showing no statistical differences between them (P >0.05, one-way ANOVA with Fisher’s LSD 160 
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test). There was, however, a statistically significant difference between the first three strains 161 
(630, 630∆erm or 630∆erm A+B-) and the second set of three strains (630E, 630E A+B- or 162 
630E A+B- CT) (P < 0.0001). The C. DIFFICILE TOX A/B II™ ELISA does not differentiate 163 
between toxin A and B. In order to be able to quantify each toxin, the kits from TGCbiomics 164 
were used (Fig. 4B and 4C). The toxin A ELISA showed significantly higher production in strain 165 
630Δerm compared to 630E (p<0.0016) and also confirmed the previous observations that 166 
strains with impaired tcdB, produce more toxin A 8, 9 (Fig. 4B). No toxin B production was 167 
seen, as expected, in the tcdB-mutants. Strains 630 and 630Δerm, however, both produced 168 
significantly more toxin B than 630E (p<0.0001) (Fig. 4C). 169 
 170 
Whole genome sequencing 171 
To establish whether strains 630E and 630Δerm, and derivatives, contained any 172 
additional changes to the ermB gene deletion, relative to the parent strain 630, the following 173 
strains were sequenced using Next Generation Sequencing platforms: 630E A+B-, 630E A+B- 174 
CT on Illumina HiSeq (GATC, Germany) and 630Δerm A-B on a Roche 454 (Deepseq, 175 
University of Nottingham, UK) and the data compared to the published genome of the 176 
parental strain 630 12 and previously sequenced 630ΔermΔpyrE. 19 We used a frequency of 177 
70% as a cut-off for SNP calling and found multiple SNPs, InDels and other minor changes, 178 
both common and unique to 630, 630E and 630Δerm. In total, two SNPs in coding regions 179 
with non-synonymous changes were found that were common to all three strains (in 180 
CD630_11900, encoding an acyl-CoA N-acyltransferase where SNP changes 181 
phenylalanine133 to leucine and in CD630_13880, a pseudo gene where a frameshift is 182 
introduced). In addition to these, we found in both 630 and 630Δerm strains three SNPs (two 183 
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in intergenic regions and one in a coding region of CD630_2667, encoding the BC domain of 184 
a glucose PTS, changing valine228 to isoleucine). 630Δerm had seven unique changes 185 
compared to 630 and 630E (including six non-synonymous SNPs in coding regions), while 186 
630E had eleven SNPs (with nine non-synonymous SNPs in coding regions) not found in the 187 
other two strains. SNPs were confirmed by Sanger sequencing and thereafter by RNAseq 188 
data (see below). Indeed, the SNPs found in the DNA-seq data were validated by using 189 
the RNA-seq sequence reads mapped on the genome sequence with Bowtie2 20 with each 190 
position being checked using Tablet 21. A complete list of SNPs and other small changes are 191 
indicated in Table 1 and in supplementary Table S1. During the preparation of this 192 
manuscript a new sequence of 630 was published by Riedel et al. 22. We incorporated their 193 
data into Table 1 (and Table S1). Overall this new sequence shows very few disparities to 194 
the original one. However two SNPs found in our data were attributed to mistakes in the 195 
original sequence (in CD630_17670 and CD630_31561). Another paper was recently 196 
published by van Eijk et al., 23 resequencing 630Δerm. Overall there are very few 197 
discrepancies between their data and our findings, confirming the quality of both data sets. 198 
We have incorporated their findings into Table S1. 199 
It may be assumed, that during the repeated subculture of strain 630 undertaken in the 200 
Mullany 13 and Rood 14 laboratories, sub-populations within the culture were isolated 201 
carrying SNPs. However, it seems improbable that the two SNPs (Table 1), common to all 202 
three strains, arose independently. Rather we hypothesise that these SNPs might be 203 
sequencing mistakes. This theory gains weight through the new sequencing data by Riedel 204 
et al. 22. Two SNP changes which we identified originally between the published 630 205 
sequence and our data were confirmed by Riedel et al to also be the sequence of their 630 206 
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seed stock. Unfortunately the genome announcement 22 does not state the exact source of 207 
their 630 strain. As mentioned above another three SNPs were only found in 630 and 208 
630Δerm, two of these are in intergenic regions which showed no expression in our RNAseq 209 
experiment, and the third is located in a PTS gene in 630 and 630Δerm (position 3080703, 210 
Val228Ile). Rather than having occurred independently it is more likely that these SNPs arose 211 
in the Mullany laboratory, subsequent to provision of chromosomal DNA to the Sanger 212 
Centre for determination of the 630 genome sequence 12, and before the strain 630 was 213 
passaged to obtain 630Δerm. At the time, C. difficile strains in the Mullany laboratory were 214 
routinely stored at 4°C as Robertson’s Cooked Meat stocks, as opposed to being frozen at -215 
80°C in 10% glycerol (A.R. Roberts, personal communication). On this basis, the traditional 216 
microbiological practice of using Robertson’s Cooked Meat to curate strains might not be 217 
ideal as strains are not entirely dormant and genome changes can occur over time. The SNPs 218 
that were found to be unique to 630Δerm and 630E (n=8 and n=11, respectively) can be 219 
assumed to have been accrued at some point after the two 630 populations diverged, that 220 
is when the strain was sent to the Rood laboratory. It is most likely, although not certain, 221 
that the majority, if not all of the strain-specific SNPs arose during the repeated subculture 222 
experiments undertaken to isolate the ermB deletion strains 630E and 630Δerm. 223 
Changes specific to 630Δerm include SNPs in three intergenic regions, which all have 224 
been determined with a coverage of over 150 and 100 % frequency (see Table 1). The other 225 
five changes comprise four non-synonymous SNPs and an insertion. The insertion has 226 
previously been reported by Rosenbusch et al.24 and was confirmed by van Eijk et al. 23 and 227 
is an 18 bp duplication in spo0A, the master regulator of sporulation. This insertion might be 228 
responsible for the reduced sporulation frequency seen in strain 630 and also in 630E and 229 
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derivatives, which do not carry this duplication (which does not have this duplication) (Fig. 230 
3A). The SNPs have been found in the following genes: CD630_08260, encoding a ferric 231 
uptake regulator (perR homologue) (Thr41Ala); CD630_19070, encoding an alcohol 232 
dehydrogenase homologue (eutG) (Gly252Glu); and CD630_35630, encoding a transcriptional 233 
regulator of the GntR family (Ala91Val).  234 
In contrast, strain 630E contains a larger number of non-synonymous SNPs including 235 
changes that result in nonsense mutations and in one case the inversion of a small segment 236 
of DNA preceding a flagella operon. We found two changes in intergenic regions, one with 237 
100 % frequency and a coverage of 94 (position 3528736); the other at a much lower 238 
frequency (41 %), but confirmed a 150 bp inversion by Sanger sequencing in the promoter 239 
region of flgB, the first gene in a F3 flagella operon (early flagella genes). Non-synonymous 240 
SNPs were found in CD630_07610, encoding a putative RNA helicase (Asp136Tyr); 241 
CD630_14040, encoding an oligopeptide transporter (Glu536Gly); CD630_20270, encoding a 242 
hydrolase (Gly373Glu); CD630_29430, encoding a phage replication protein (Asn210Asp); and 243 
CD630_33790, encoding a conjugative transposon protein (Glu63Asp). Finally, there is 244 
another SNP at position 3034953, in gene CD630_26270 (Gly68Cys), encoding a conserved 245 
hypothetical protein. Interestingly the new genome sequence from Eijk et al. 23 suggested 246 
an “A” at position 3034953 in contrast to the earlier annotation suggesting “C”. The new 247 
annotation is in line with our RNAseq data (Table S1) and taken into account our sequencing 248 
data (Table 1) suggests that this is indeed a mutation in 630E and was miss-annotated in the 249 
original sequence. In one instance the nucleotide substitution resulted in the creation of a 250 
nonsense, stop codon, and as a consequence a severe, premature truncation of the encoding 251 
protein. Thus, the stop codon introduced into CD630_12740 encoding a topoisomerase I 252 
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(topA) homologue (Gln386*) truncated the protein from 695 amino acids to 385 amino acids. 253 
Conversely, in the case of the glucose PTS operon ptsG-BC, the conversion of the stop codon 254 
of ptsG-B gene (CD630_26670) to a Glu codon (*524Glu) resulted in its fusion to the coding 255 
region of the immediately downstream ptsG-C gene.   256 
Virulence testing of 630Δerm, 630E and mutants using an in vivo model  257 
In order to confirm previous data and to rule out differences in experimental set up in 258 
different laboratories, the virulence of 630E and derivatives was assessed using the hamster 259 
infection model in our laboratory (University of Nottingham) as previously described. 9  260 
Figure 5 shows the times from infection to endpoint (in days) for the hamsters infected 261 
with 630E, 630E A+B- and 630E A+B- CT. For comparative purposes data for infection with 262 
630Δerm and 630Δerm A+B- from a previous study 9 is also included.  The latter emphasises 263 
the fact that all eight hamsters infected with strain 630Δerm were colonised and succumbed 264 
to C. difficile disease (with an average time of 3.25 days from infection to endpoint). This is 265 
in direct contrast to what is observed with 630E where of the five animals successfully 266 
infected, only three were colonised till the respective endpoints and of these, two 267 
succumbed to disease (at day two and six). Two animals lost colonisation after days 15 and 268 
18, respectively. 269 
In our previous study 9 seven, of the eight animals infected with 630∆erm A+B- (as also 270 
shown in Fig. 5), succumbed to disease with an average time to death of colonised hamsters 271 
being just under two days. One animal showed no signs of disease until the experimental 272 
endpoint, but was found not to have been colonised. Here of the 11 animals infected with 273 
the equivalent mutant of strain 630E (630E A+B-), only two animals succumbed to CDI (on 274 
day two and nine). Four animals in this group were never colonised, one lost colonisation 275 
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after day three and the others were colonised till endpoint. Six animals were infected with 276 
630E A+B- CT, and of these two hamsters developed infection (day three and five). Two of 277 
the surviving animals lost colonisation after day 15 and 18 respectively. (Fig. 5 and Table S2).    278 
The difference between the average time to death of all hamsters administered 279 
630∆erm and 630∆erm A+B- was found not to be statistically significant (one-way ANOVA, 280 
p=0.5355) (results from Kuehne et al. 9). Similarly, the differences between the average 281 
times to death of all animals administered 630E, 630E A+B- and 630E A+B- CT was not 282 
statistically significant (one-way ANOVA, p=0.8919). In contrast, the difference between the 283 
630∆erm strain (and derivative) and the 630E strain (and derivatives) was statistically 284 
significant (one-way ANOVA, p>0.0001).   285 
 286 
Correction of SNPs in strain 630E 287 
In view of the large number of SNPs present in strain 630E, it was impractical to change 288 
them all back to the 630 parental sequence. We therefore selected just three specific 289 
mutations present in 630E and converted them back to the sequence present in the parental 290 
strain, 630.    291 
Our principal target was to remove the stop codon from within the topoisomerase I gene, 292 
CD630_12740, as this enzyme plays a central role in the regulation of DNA negative 293 
supercoiling and its inactivation is likely to result in extensive pleiotropic effects. Indeed, in 294 
some bacteria its inactivation is lethal. 25-27 Moreover, bacterial genes related to 295 
pathogenesis and virulence have been shown to be sensitive to topA mutation in E. coli, 28 296 
S. flexneri, 29 Yersinia enterocolitica 30 and Salmonella. 31 We therefore converted the “T” 297 
nucleotide at position 1480649 in 630E back to an “A” nucleotide, thereby removing the 298 
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nonsense stop codon and allowing the production of full length native topoisomerase 299 
enzyme.   300 
As a second target we elected to correct the inversion of DNA upstream of the F3 flagella 301 
operon. As strain 630E is non-motile, and as the inverted region encompasses the non-302 
coding region immediately upstream of the flgB gene, it is likely to have disrupted the 303 
promoter responsible for both flgB expression and the genes in the downstream operon. 304 
The inversion is therefore likely to be the principal cause of the loss of motility in 630E. 305 
Furthermore, factors affecting flagella expression can also influence toxin expression levels. 306 
32, 33   307 
Finally, we sought to correct the fusion of the two PTS components ptsG-B and ptsG-C, by 308 
resurrection of the stop codon of ptsG-B through the conversion of the “C” nucleotide at 309 
position 3079815 back to an “A” nucleotide. As glucose is known to affect toxin production, 310 
through catabolite repression, 34, 35 it was reasoned that this particular SNP could be 311 
affecting toxin expression, and therefore virulence.  312 
The plasmids carrying the 630 wildtype alleles necessary for the correction of the three 313 
targeted SNPs were assembled as described in Materials and Methods and then used to 314 
effect the replacement of the 630E mutant alleles by allelic exchange. 15  To verify that the 315 
mutant clones obtained were correct, each targeted region was amplified by PCR using 316 
appropriate oligonucleotide primers and the DNA fragments obtained subjected to Sanger 317 
sequencing on both DNA strands. In every case, clones carrying the desired ‘corrected’ 318 
sequence were obtained. The new strains were named after the genes or regions that were 319 
corrected, namely 630E_topA, 630E_CD2667 and 630E_flgB, respectively.  320 
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To assess the effects of the changes on the characteristics of the mutant strains, growth 321 
rate, sporulation and germination, motility, and in vitro cytotoxicity and toxin production 322 
(ELISA) were measured. None of the three corrected mutants exhibited any difference in 323 
growth rate compared to the parental strain 630E (data not shown). Similarly, sporulation 324 
and germination remained unaffected (data not shown). Toxicity testing revealed no 325 
difference to 630E using the C. DIFFICILE TOX A/B II™ ELISA assay kit from TechLab (Fig. 4A). 326 
To quantify toxin A and toxin B individually the ELISA kits from TGCbiomics were used to 327 
assay 630E_topA and 630E_CD2667 (Fig. 4B). No differences were measured for toxin A, but 328 
the strain 630E_topA showed significantly higher levels of toxin B than the parental strain 329 
630E. 330 
 331 
Transcriptomic comparison of 630, 630∆erm and 630E 332 
RNA was extracted from strains 630, 630∆erm and 630E at 6, 14 and 24 h and used in 333 
an RNAseq experiment as described in Materials and Methods. The Principal Component 334 
Analysis (PCA) (Fig. 6) showed that strain 630∆erm and 630E are closely correlated on a 335 
transcriptional level which is significantly separated from 630. While this result implies that 336 
both strains are fundamentally different to the parental strain, it does not indicate that the 337 
differences to 630 are the same for both strains. The analysis depicted by the Venn diagram 338 
(Fig. 7) confirms the results of the PCA, showing that the majority of differentially expressed 339 
genes are observed comparing 630∆erm and 630E to 630. From a total of 1337 differentially 340 
expressed genes (Table S3 contains all the genes differentially expressed along the growth 341 
and also comparisons between the strains), only 139 were common between all three 342 
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strains. A total of 345 were common between 630E and 630∆erm, 60 were common 343 
between 630 and 630∆erm and 58 were common between 630 and 630E. 344 
Most of the 345 genes differentially expressed in both, 630∆erm and 630E, were either 345 
up or down-regulated in the same way highlighting again how distinct the two strains are 346 
from the parental strain 630 (Table S3). In TY medium used for the transcriptomic 347 
experiments, known as a non-optimal for spore production, a total of 44 sporulation genes 348 
were differentially expressed in both 630∆erm and 630E, and all of these were 349 
downregulated at 14 and 24 h compared to 6 h. No further differentially expressed 350 
sporulation genes appeared in 630∆erm, however, our analysis showed a further 22 351 
sporulation genes, of which 21 were downregulated, in 630E. Amongst these was the master 352 
regulator of sporulation spo0A. Nine genes classed as stress-related are differentially 353 
expressed in all three strains (five upregulated), with a further three in 630 (all upregulated), 354 
seven in 630∆erm (four upregulated) and 16 in 630E (11 upregulated). Nine genes related to 355 
secretion are down regulated in 630E and one gene related to type IV pili is upregulated. In 356 
comparison only one secretion gene (putative pilus assembly ATPase) is differentially 357 
expressed only in 630∆erm (down regulated) and none in 630. Metabolism is also highly 358 
differentially regulated in the three strains. 90 genes were uniquely, differentially expressed 359 
in 630E, 50 in 630∆erm and 30 in 630. In particular the amino acid metabolism stands out 360 
for 630E with the majority of genes being downregulated. (Table S3). 361 
RNAseq data can be used to independently corroborate genome re-sequencing data.  362 
Thus, it was apparent that those changes identified by CLC Bio as being present with a 363 
frequency of 70% or less, except for CD630_20102, were not real accordingly to the RNAseq 364 
analysis (Table S1). This increases the confidence in disregarding changes identified by NGS 365 
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with a low frequency. In most cases, the SNPs and Indels identified by NGS were confirmed 366 
by the RNAseq analysis, with the following exceptions: for SNPs in 630E we found two 367 
disagreements notably in CD630_33790 and CD630_29430, which both had 100 % frequency 368 
and a high coverage (around 200 reads) in the DNA sequence analysis, but only low coverage 369 
in the RNAseq experiment.  Due to the low coverage of these regions during the RNAseq 370 
experiment, which is indicative of low or no expression under the examined conditions, a 371 
sequencing error cannot be excluded. For the SNP in CD630_12740 the RNA coverage 372 
corroborated the genomic data for 630E, but was in disagreement with the genomic data 373 
for 630 and 630∆erm. For three SNPs in 630∆erm similar scenarios were observed. 374 
CD630_19070 had very low RNA coverage, CD630_35650 showed ambiguous RNA data with 375 
low coverage for 630E. CD630_08260, the perR homologue, had convincing DNA data, with 376 
frequencies of 98-100 % and coverage of at least a 100 which was corroborated for 630∆erm 377 
by RNAseq coverage.  378 
In terms of actual expression data (Table S1), CD630_07610 (the RNA helicase), 379 
CD630_14040 (oligopeptide transporter), CD630_20270 (hydrolase) and CD630_29430 380 
(phage replication protein) all showed differential expression in 630E compared to the other 381 
two strains, with the first two showing reduced expression and the latter two an increase.  382 
CD630_29430, however, also showed an increase in expression in 630 at the later time point. 383 
Changes in CD630_26670 in 630∆erm and 630E both seem to lead to severely reduced 384 
expression. CD630_12740 (topA) only showed differential expression at 24 h in 630∆erm and 385 
CD630_12140 (spo0A) expression was severely reduced in 630E. 386 
 387 
Discussion 388 
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Previously, two studies 8,9 have attempted to use isogenic mutants defective in the 389 
production of either toxin A or toxin B to determine the relative importance of these two 390 
virulence factors in CDI using the hamster infection model. However, despite generating 391 
essentially equivalent A+B-insertion mutants in ostensibly the same strain of C. difficile 392 
(630), contradictory outcomes were obtained in terms of the importance of toxin A. Thus, a 393 
tcdB mutant created in the one study 8 producing only TcdA did not cause disease in the 394 
hamster, whereas the equivalent ClosTron mutant made in our laboratory (Minton group) 9 395 
remained virulent. The work undertaken here has provided compelling evidence that the 396 
reason for the observed conundrum resides in the use of two different erythromycin-397 
sensitive derivatives of strain 630.  398 
Here we have shown that both erythromycin-sensitive derivatives, 630E 14 and 630∆erm 399 
13 carry a significant number of SNPs compared to the published sequence. Moreover, it is 400 
clear that whilst the phenotypic properties of 630∆erm and its mutant derivatives closely 401 
resemble that of the parent strain 630, strain 630E and its progeny exhibit substantive 402 
differences. Thus, whereas latter strains exhibit reduced growth rates, are less proficient in 403 
spore formation and are non-motile, 630∆erm strains mirror the behaviour of the 630 404 
parental strain with respect to these phenotypes. Furthermore, 630E strains produce 405 
reduced amounts of toxin and both struggle to colonise hamsters, and once colonised, 406 
animals are less likely to succumb to disease. In short, 630E and its derivatives (i.e., 630E A-407 
B+ and 630E A+B- CT) are less virulent than 630∆erm and its mutant counterparts (i.e., 408 
630∆erm A+B-).    409 
The altered properties of 630E and its derivatives are undoubtedly a consequence of 410 
the observed SNPs. However, the substantive number of changes involved makes it difficult 411 
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to assign any particular SNP to a specific alteration in the observed phenotype, particularly 412 
as a combination of mutagenic changes could be responsible. Whilst it is now possible to 413 
make precise changes to the genome using allelic exchange methodologies 15 it is not 414 
practically feasible to make all of the sequential rational changes needed to definitively 415 
identify the mutation(s) responsible for a particular phenotype. As such, we only corrected 416 
three specific SNPs that we reasoned may be making a significant contribution. The 417 
outcomes of these experiments only emphasised the difficulty of such an undertaking, and 418 
served to highlight the dangers involved in making assumptions. Thus, whilst it seemed 419 
reasonable to assume that the DNA inversion within the promoter region of the flagella 420 
operon was likely to have caused the observed non-motile phenotype, this surprisingly 421 
proved not to be the case. Re-inversion of the 150 bp region failed to restore motility. Clearly 422 
other SNPs are at least partly responsible for the observed lack of motility. Singling out any 423 
other SNP as the culprit would in the absence of experimental evidence be 424 
counterproductive. 425 
Equally negative was the observed outcome of correcting the mutation in CD630_12740 426 
that results in a truncation of the encoded topoisomerase I enzyme. Given this enzyme 427 
controls DNA supercoiling, and given that its mutation in certain bacteria is either a lethal 428 
event 25-27 and/or is involved in the regulation of virulence factors, 28-30 it seemed likely that 429 
its presence would result in pleiotropic effects that could have contributed to the observed 430 
phenotypic changes. However, its correction, with the exception of a measurable increase 431 
in toxin B levels, seemingly had no effects on the behaviour of the strain, at least for those 432 
properties measured. The reasons are not clear. In other bacteria, mutations of topA are 433 
only isolated if compensatory mutations arise elsewhere in the genome. 26  Whether any of 434 
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the other SNPs present in 630E (eg., the RNA helicase mutation) are negating the effects of 435 
the TopA truncation is currently unknown.   436 
To understand the differences observed further, we analysed the transcriptome of 630, 437 
630∆erm and 630E, comparing expression at 6 h to 14 h and to 24 h (Table S3). The data 438 
corroborated the phenotypic analysis, showing vastly different transcriptomes for all three 439 
strains. While 630E and 630∆erm cluster together in the PCA (Fig. 6), this only highlights how 440 
different the two strains really are from the progenitor. The analysis clearly shows that the 441 
three strains are very different from each other and also serves as an explanation as to why 442 
the change of a single SNP could not restore any given phenotype. Overall 630E seems the 443 
most divergent with many genes differentially expressed involved in metabolism and 444 
regulation (Table S3). Additionally 32 genes grouped under the descriptor ‘cell factor’, many 445 
of which play a role in energy metabolism, are differentially expressed in 630E, with only six 446 
of these being upregulated. In contrast out of 19 genes in 630, 11 are upregulated and, out 447 
of 10 in 630∆erm, six were upregulated. The number of genes downregulated in energy 448 
metabolism in 630E might relate to the growth differences seen between the strains.  449 
Interestingly 22 genes involved in sporulation are differentially expressed, 21 of these 450 
downregulated, in 630E versus one in 630 and two in 630∆erm. This is consistent with the 451 
observed delay in sporulation and reduced amount of spores produced by 630E. Secretion 452 
also seems most affected in 630E, with 10 genes differentially expressed, compared to none 453 
in 630 and one in 630∆erm.  A general defect in secretion could affect the secretion of certain 454 
virulence or adhesion factors. Furthermore, 33 cell wall genes are differentially expressed in 455 
630E (compared to 14 each in 630∆erm and 630). This may also contribute to the observed 456 
colonisation deficiencies. Mobile elements are, however, more differentially transcribed in 457 
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630 and 630∆erm (15 each) versus 630E (nine). As in many cases different pathways were 458 
affected, we propose that this could at least in part explain the different adaptability and 459 
virulence of the two strains. In both strains many regulators were differentially affected 460 
providing a further basis for the observed phenotypic variation between strains. 461 
 462 
Conclusion 463 
Our study has established that the parental strains (630E and 630∆erm) used in the two 464 
previous studies, that explored the relative roles of toxin A and toxin B in disease, 8, 9 are 465 
phenotypically and genetically distinct. Here we also reveal that the three strains (630, 466 
630∆erm and 630E) have vastly different transcriptomes, which no doubt lead to the 467 
different phenotypes observed. This immense diversity also underlines our finding that by 468 
restoring just one SNP, the entire transcriptome cannot be changed. The presence of SNPs 469 
in strain 630E significantly affects its transcriptome which in turn has a significant impact on 470 
growth, sporulation and finally virulence of this strain in the hamster model of infection 471 
under the conditions tested. Data (such as motility, toxicity and virulence) obtained with 472 
strain 630∆erm reflects more accurately the behaviour of the parent strain 630. As such, it 473 
may be concluded that 630 producing toxin A alone will cause disease in the hamster. As a 474 
consequence, toxin A should remain a target for the rational development of effective 475 
countermeasures against C. difficile.   476 
This study has also highlighted a number of issues that need to be borne in mind in the 477 
future. At a specific level, if researchers wish to undertake genetic-based studies with strain 478 
630, then the use of strain 630∆erm should be favoured over strain 630E. At a more 479 
fundamental level, researchers need to effectively curate their strains to prevent the 480 
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inadvertent isolation of SNPs. Ideally, master seed banks need to be established as frozen 481 
glycerol stocks. Moreover, the genome of the stored strain should be re-sequenced as part 482 
of the storage process whenever a strain is received from external sources, regardless of 483 
whether it has been re-sequenced in the sending laboratory.  484 
 485 
Materials and Methods 486 
Bacterial strains and routine culture conditions 487 
Bacterial strains and plasmids used in this study are listed in Table 2. E. coli was cultured 488 
aerobically at 37°C with shaking at 200 rpm in LB medium with chloramphenicol 489 
supplementation (25 μg/ml) where appropriate. C. difficile was cultured in TY (tryptose 490 
yeast) medium supplemented with thiamphenicol (15 μg/ml) where appropriate. When 491 
needed, C. difficile strains were plated on BHIS agar (Brain Heart Infusion agar [Oxoid] 492 
supplemented with 5 mg/ml yeast extract [Oxoid] and 0.1% [wt/vol] cysteine [Calbiochem]) 493 
supplemented with d-cycloserine (250 μg/ml), cefoxitin (8 μg/ml) [Oxoid] (BHIScc). 494 
Fluorocytosine selections were carried out on C. difficile minimal medium (CDMM) as 495 
described previously.  15 All C. difficile cultures were incubated at 37°C anaerobically in an 496 
anaerobic MACS1000 workstation (Don Whitley, Yorkshire, UK).  497 
Mutant nomenclature 498 
For the sake of simplicity, C. difficile strains that carried a tcdA insertional mutant were 499 
referred to as A-, those carrying a tcdB mutant as B-, and those strains carrying a mutation 500 
in both genes as A-B-. To avoid any ambiguity, if the gene was not inactivated it was referred 501 
to as A+ or B+, as appropriate. Thus, a tcdA mutant of 630Δerm constructed using ClosTron 502 
technology as described, 9, 16 was designated 630Δerm A-B+. The equivalent mutant in 630E 503 
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constructed through the insertion of a replication-deficient plasmid, according to the 504 
method of O’Connor et al., 14 was designated 630E A-B+. When ClosTron technology was 505 
used in 630E, this was clarified by adding a ‘CT’ suffix, 630E A-B+CT to the strain designation. 506 
 507 
Whole genome sequencing and bioinformatics 508 
Genomic DNA from strains 630E A+B-, 630E A+B-CT and 630Δerm A+B- was prepared by 509 
phenol:chloroform extraction. 630E A+B-, 630E A+B-CT, 630Δerm(ΔpyrE) were sequenced 510 
on Ilumina highseq (GATC, Germany) and 630Δerm A+B- on a Roche 454 (Deepseq, 511 
Nottingham, UK) and the data compared to the published genome of 630 11,19 using CLC 512 
genomic workbench. All raw sequencing data have been deposited in the sequence read 513 
archive (SRA) under the study name PRJNA304508. The accession number is SRP066836. The 514 
sequencing data for 630ΔermΔpyrE had been obtained previously 19 and with no additional 515 
changes, other than the pyrE deletion, present compared to 630Δerm, were used to analyse 516 
the parental strain 630Δerm. We used a frequency of 70% as a cut-off for SNP calling. SNPs, 517 
InDels and inversions were confirmed by amplifying a few hundred base pairs up- and 518 
downstream of the area of interest (primers are listed in Table S4) and the amplicon was 519 
Sanger sequenced (Source BioScience, UK). This confirmation was done on all strains 520 
including the parental strains (630, 630Δerm, 630E) and the derivatives (630Δerm A+B-, 630E 521 
A+B-, 630E A+B-CT). 522 
 523 
Correction of SNPs and reversal of 150-bp region within the flagellar operon 524 
Using the method described by Cartman et al. 15 we “corrected” the two SNPs and an 525 
inversion in 630E to the 630Δerm genotype. A stretch of DNA corresponding to 526 
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approximately 500 bp either side of the area to be altered was synthesised by Biomatik and 527 
cloned into plasmid pMTL-SC7315λ2.3. This vector was transformed by electroporation into 528 
E. coli CA434 cells 36 and subsequently conjugated into 630E. Single crossover colonies were 529 
identified as those growing faster on plates containing thiamphenicol. Following overnight 530 
incubation on CDMM containing 5-fluorocytosine, colonies were incubated on BHIScc plates 531 
with and without thiamphenicol. Those strains that had lost the plasmid (both wildtype and 532 
double crossover) were unable to grow on thiamphenicol. SNP corrections were confirmed 533 
by PCR (Primers see Table S4) and Sanger sequencing (Source BioScience, UK).   534 
  535 
ClosTron mutagenesis 536 
A tcdB mutant was generated in the 630E background according to the published 537 
method, 16 using the same plasmid that was used to generate the equivalent mutant in 538 
630∆erm.  9  This newly created strain was referred to as 630E A+B- CT.  539 
 540 
Southern and Western blot 541 
The Southern and Western blot were performed as described in Kuehne et al., 2010. 9 542 
 543 
In vivo testing of mutants 544 
In vivo testing was carried out in Syrian Golden hamsters (Charles River, Germany) as 545 
previously described. 9 Briefly, clindamycin was administered orally on day -five to render 546 
the animals susceptible to infection. On day zero, 10,000 spores were administered orally. 547 
Animals were assessed for signs of CDI (weight loss, wet tail, lethargy, lack of response to 548 
stimulus) six times a day for the first five days, and once daily for the following 14 days. At 549 
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this point animals that failed to display signs of CDI were euthanised.  Faecal pellets were 550 
collected daily from day zero to endpoint, homogenised and plated on C. difficile fructose 551 
agar (CDFA). C. difficile colonies were sub-cultured onto BHIS agar and the genotype was 552 
established by PCR (primers in Table S4) followed by Sanger sequencing (results in Table S2).  553 
At the experimental endpoint, part of the caecum of each animal was collected. This was 554 
also used to plate on CDFA to verify colonisation.   555 
 556 
In vitro testing of mutants 557 
Growth curves: To assess the effects of SNPs and “corrected” SNPs/inversion on the growth 558 
characteristics of all strains, we performed growth curve experiments over 24 h. A 180 μL 559 
volume of TY medium was inoculated with 20 μL of an overnight culture in 96-well plates 560 
and incubated for 24 h in a GloMax-Multi Microplate Multimode Reader (Promega, USA). 561 
Samples were shaken every h and OD600 measurements were taken immediately after.   562 
Motility assays:  2xYTG (tryptone (1.6%), yeast (1%), NaCl (0.4%), Gelzan (0.24%)[Sigma-563 
Aldrich] and glucose (0.5%)) agar was utilised. 25 mL were poured into each petri dish and 564 
let to solidify at room temperature for 15 min. The plates were then dried at 37°C for 30 565 
min. The plates were placed into the anaerobic cabinet 24 h before use. 2 μL volumes of 566 
overnight culture were ‘dropped’ onto each plate. Plates were incubated anaerobically for 567 
48 h. Motility was assessed by eye and the plates photographed.  568 
Sporulation and germination assays: Sporulation and germination assays were carried out 569 
as previously described. 17, 18  Briefly, for the sporulation assay cultures were grown for five 570 
days, with 2 X 500 µl samples taken at 0, 24, 48, 72, 96 and 120 h. One sample from each 571 
time point was heated to 65°C for 30 min while the other sample was kept at room 572 
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temperature. After this time, samples were serially diluted from 100 to 10-7 in PBS. 3 X 20µl 573 
of each dilution was spotted onto BHIS plates containing 0.1% taurocholic acid and were 574 
incubated for 24 h. The following day, colonies were counted and CFU/mL were calculated. 575 
A 630∆erm spo0A::CT mutant strain (containing a ClosTron insertion in the spo0A gene 37), 576 
which is unable to form spores, was used as a negative control.  577 
Germination was measured as a function of the ability of a germinated spore to outgrow 578 
in the absence of taurocholate. Spore stocks were prepared as previously described by Heeg 579 
et al., 2012 38 and stored at -20°C. The optical density of spore suspensions (OD600) was 580 
adjusted to 1.0 and 450 µl was used per measurement. This equated to approximately 2.5 X 581 
107 spores. Spore suspensions were heat treated at 60°C for 25 min to kill any remaining 582 
vegetative cells and then centrifuged and resuspended in BHIS with the germinant 583 
taurocholic acid (0.1%) in a total volume of 20 ml. Samples were taken at 5, 10, 20, 30, 60, 584 
90, 120, 180 and 240 min, briefly centrifuged, washed and resuspended in phosphate-585 
buffered saline (PBS), the samples were then diluted and plated on plain BHIS agar. Plates 586 
were incubated for 24 h before the CFUs were enumerated.  Colonies that grew on these 587 
plates were considered to be germinated vegetative bacteria.   588 
 589 
Toxin A/B ELISA: ELISA assays were performed using the C. DIFFICILE TOX A/B II™ kit from 590 
TechLab and the TGC-E002-1-separate detection of C. difficile toxins A and B kit from 591 
TGCbiomics according to the manufacturers’ instructions. Cultures of C. difficile were grown 592 
in TY medium without glucose for 72 h, at which time 1 ml samples were taken, centrifuged 593 
and the supernatant filter-sterilised and used for the ELISAs. A 1:2 dilution was used for the 594 
toxin B ELISA kit from TGCbiomics.  To quantify toxins a standard curve with pure toxin (the 595 
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native antigen company) was established for the TechLab ELISA and also Toxin A ELISA from 596 
TGCbiomics. 597 
 598 
RNAseq: Total RNA was extracted from 2 independent biological replicates of 630, 630∆erm 599 
and 630E strains at 3 time points (18 samples). Bacteria were grown in TY broth medium 600 
after 6, 14 and 24 h as previously described. 35  The mRNA was treated with MicrobExpress 601 
kit (Ambion). For oriented RNA-seq library construction, the Truseq stranded RNA seq 602 
Illumina kit was used according to manufacturer’s instructions before sequencing using the 603 
Illumina HiSeq 2500 machine. Sequencing reads were mapped using Bowtie 39 to the 604 
reannotated 630 reference genome 40 complemented with the known ncRNA. 41  Statistical 605 
analyses were performed on each strand coverage count with DESeq2 42 using the 6 h value 606 
as a reference for reporting the expression data of 14 and 24 h. A gene was considered 607 
differentially expressed when the fold change was > 2 and the P value was < 0.05. 608 
The RNA-seq data discussed in this publication have been deposited in NCBI’s Gene 609 
Expression Omnibus database under the accession no. GSE72006  610 
RNA-seq coverage visualization is available through the COV2HTML software: 43  611 
630 
14H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-20 
24H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-22 
630∆erm 
14H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-24 
24H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-26 
630E 
14H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-28 
24H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-30 
 612 
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Graphs and statistical analyses 613 
All graphs were generated and statistical analyses were performed using GraphPad 614 
PRISM 6.02. Statistical analysis comprised either 2-way ANOVA for multiple comparisons or 615 
unpaired t test for pairwise comparisons. All experiments were carried out in triplicate 616 
unless stated otherwise. 617 
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Figure legends 759 
 760 
Figure 1.  Growth curves of strain 630 and its derivatives. A. 630 (630), 630Δerm and 630E were 761 
grown in TY-broth for 24 h in a 96 well plate reader. The optical density at 600 nm was measured 762 
every 30 min. B. This graph shows the same growth as A. and in addition the growth of derivatives 763 
630Δerm A+B-, 630E A+B- and 630E A+B- CT. 764 
 765 
Figure 2.  Motility assays. The assay was carried out by inoculating overnight cultures onto motility 766 
agar plates and incubating anaerobically for 48 h. Strains 630, 630∆erm and 630E were compared for 767 
their ability to swarm. 768 
 769 
Figure 3.  Sporulation and Germination.  A. Sporulation over 120 h comparing heat treated CFUs of 770 
strains 630, 630∆erm, 630∆erm A+B-, 630E, 630E A+B- and 630E A+B- CT with a non-sporulating 771 
control (spo0A). B. The extent of germination of the indicated strains was measured over 250 min as 772 
the ability of germinated spores to form colonies on plates lacking taurocholate.    773 
 774 
Figure 4.  Toxin ELISAs. A. The C. DIFFICILE TOX A/B II™ ELISA assay kit from TechLab was used to 775 
measure combined toxin A and B in strains 630, 630∆erm, 630∆erm A+B-, 630E, 630E A+B-, 630E 776 
A+B- CT, 630E_topA, 630E_flgB and 630E_CD2667 grown in TY for 72 h. B. and C. Toxin ELISAs 777 
TGCbiomics, measuring the toxins separately were used to quantify toxin A (B) and toxin B (C) 778 
produced by strains 630, 630∆erm, 630∆erm A+B-, 630E, 630E A+B- and 630E A+B- CT grown in TY 779 
for 72 h. Statistics were performed using one-way ANOVA with Fisher’s LSD test. 780 
 781 
Figure 5.  Infection to endpoint in the Hamster infection model.  Groups of Golden Syrian Hamsters 782 
were challenged with C. difficile 630E (5 hamsters), 630E A+B- (11 hamsters) and 630E A+B- CT (6 783 
hamsters). The graph represents the time from inoculation to endpoint. The maximal duration of the 784 
experiment was set to 20 days. Animals represented in open symbols, have not been colonized 785 
despite challenge or lost colonization before day 20. Details can be seen in Table 1. The dotted line 786 
separates this experiment from data obtained by Kuehne et al. 9, which are represented here as a 787 
comparator. In that study 8 hamsters were infected with C. difficile 630Δerm and another 8 hamsters 788 
with 630Δerm A+B-. 789 
 790 
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Figure 6. Principal Component Analysis (PCA).  The Principal Component Analysis (PCA) visualizes the 791 
variance of the data in a single graph. The axis represent the two largest variances of the data; PC1 792 
accounts for 42% and PC2 accounts for 21%, that means that 63% of the total variance of the dataset 793 
is explained in this graph. The third component accounts for less than 10% and further components 794 
have a value that falls rapidly. The PCA represents the RNAseq data (at three different time points, 795 
six, 14 and 24 h) in duplicate for 630 (blue), 630Δerm (green) and 630E (orange). The different time 796 
points are represented as dots in the different shades of the respective colour as indicated in the 797 
colour legend. 798 
 799 
Figure 7. Venn Diagram representing differentially expressed genes in the three different strains. The 800 
diagram summarises the output from the RNAseq data, comparing strains 630, 630Δerm and 630E. 801 
It depicts all differentially expressed genes and shows how many genes are differentially expressed 802 
in all strains, in two of the strains or are unique to just one strain.  803 
  804 
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Table 1. Single Nucleotide Polymorphisms (SNPs) and other changes found after re-sequencing.  
 
Gene Description Position 630 12   630 22 630  C F 630Δerm C F 630E C F AA 
630E 
CD630_07610 
Putative ATP-dependent RNA 
helicase 
933139 
G - - 
  
- 
  
T 
199 100 Asp136Tyr 
CD630_14040 
Putative oligopeptide 
transporter 
1626977 
A - - 
  
- 
  
G 
187 100 Glu536Gly 
CD630_20270 
N-carbamoyl-L-amino acid 
hydrolase 
2339506 
G - - 
  
- 
  
A 
73 100 Gly373Glu 
CD630_26670 PTSG-BC 3079815 A - -   -   C 165 100 *524Glu 
CD630_26270 Hypothetical protein 3034953 C A A   A   - 156 100 Gly68Cys 
CD630_33790 
conjugative transposon 
protein 
 
3951559 C - - 
  
- 
  
A 
307 100 Glu63Asp 
CD630_12740 topA 1480649 C - -   -   T 146 100 Gln386* 
CD630_29430 
Putative phage replication 
protein 
 
3422569 T - - 
  
- 
  
C 
 
195 
 
100 Asn210Asp 
IG Intergenic region 309208 - - -   -   INV 129 41  
IG Intergenic region 3528736 G - -   -   T 94 100  
630Δerm 
CD630_19070 eutG 2209236 G - -   A 127 97    Gly252Glu 
CD630_35650 
GntR family transcriptional 
regulator 4166495 G - -   A 182 100 -   Ala91Val 
IG Intergenic region 2937176 C - -   A 173 100 -    
IG Intergenic region 3005866 T - -   G 156 100 -    
IG Intergenic region 3591103 G - -   A 211 100 -    
CD630_12140 spo0A 1413057 - - -   
AGAATGTA
GGAAATAT
AG 112 40 -   Insertion 
CD630_08260 Ferric uptake regulator 1000995 A - - 100 100 G 153 100 - 170 98 Thr41Ala 
630 
CD630_32450 prdR 3797112 C - T 117 100 -   -   Glu261Lys 
35 
 
CD630_02050 
Transcription antiterminator, 
PTS operon regulator 
 
268934 G - T 
 
123 
 
97 -   -   Gly165Cys 
630 and 630Δerm 
CD630_2667 PTSG-BC 3080703 C - T 75 100 T 141 100 -   Val228Ile 
IG Intergenic region 2203033 A - T 105 100 T 174 99     
IG Intergenic region 4007463   C 10 100 C 62 100     
630 and 630Δerm and 630E 
CD630_11900 acyl-CoA N-acyltransferase 1391850 T - C 118 100 C 133 100 C 143 100 Phe133Leu 
CD630_13880 pseudo 1607453 INS 1 - T 119 94 T 175 94 T 124 88 Thr16fs 
Mistake in original sequence 
CD630_17670 gapB 2044514 C G G   G   G    
CD630_31561 pseudo 3686535 INS 1 A A   A   A    
 
 
The table shows the Single Nucleotide Polymorphism (SNP) changes in 630∆erm and 630E compared to the reference 630 12 and also the new annotation by 
Riedel et al (The column ‘Gene’ represents the gene (or intergenic region (IG)) in which the change occurs, the column ‘position’ indicates the exact nucleotide 
position of the change.). 22 It also contains SNP frequency (F) and genomic coverage (C) as well as the resultant amino acid change (AA). No change from the 
original 630 annotation 12 is represented by a dash (-).  
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Table 2.  Strains and plasmids used in this study. 
 
Name Description Source 
Bacterial strains 
E. coli TOP 10 F– mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ (ara 
leu) 7697 galU galK rpsL (StrR) endA1 nupG 
Invitrogen 
E. coli CA434 Conjugation donor Williams et al. 36 
C. difficile 630 Wild-type Brendan Wren 
C. difficile 630Δerm Erythromycin sensitive strain of C. difficile 630 Hussain et al. 13 
C. difficile 
630Δerm(ΔpyrE) 
C. difficile 630Δerm containing a deletion in 
the pyrE gene 
Ng et al. 19 
C. difficile 630E Erythromycin sensitive strain of C. difficile 630 Lyras et al. 8 
C. difficile 630Δerm 
A+B- 
C. difficile 630∆erm tcdB-1511a::intron ermB Kuehne et al. 9 
C. difficile 630E A+B- C. difficile 630E Lyras et al. 8 
C. difficile 630E A+B-
CT 
C. difficile 630E tcdB-1511a:: intron ermB This study 
C. difficile 630E_topA C. difficile 630E This study 
C. difficile 630E_flgB C. difficile 630E This study 
C. difficile 
630E_CD2667 
C. difficile 630E This study 
Plasmids   
pMTL007C-E2:tcdB-
1511a 
ClosTron plasmid containing retargeted region 
to tcdB at IS 1511 (antisense oriented) for C. 
difficile 630∆erm or 630E 
Kuehne et al. 9 
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pMTL-
SC7315λ2.3::topA 
pMTL-SC7315λ2.3 containing 1,000 bp 
homology arms to change nucleotide 1480649 
from T to C in 630E 
This study, based on 
Cartman et al. 15 
pMTL-
SC7315λ2.3::flgB 
pMTL-SC7315λ2.3 containing 1,156 bp 
homology arms to reverse the inversion 
upstream of flgB in 630E 
This study, based on 
Cartman et al. 15 
pMTL-
SC7315λ2.3::CD2667 
pMTL-SC7315λ2.3 containing 1,000 bp 
homology arms to change nucleotide 3079815 
from C to A in 630E 
This study, based on 
Cartman et al. 15 
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Supporting Information 
 
Figure S1.  Southern and Western blot of 630E A+B- CT. A. Southern blot showing the single ClosTron 
insertion to create 630E A+B- CT (mutant 1, 2 and 3). The ClosTron plasmid pMTL007C-E2:tcdB-1511a 
was used as a positive control and the parental strain 630E as a negative control. The probe used 
binds to the intron insertion.  B. Western blot using an anti-TcdA antibody to detect production of 
toxin A in the supernatant of 630, 630Δerm, 630Δerm A+B-, 630E, 630E A+B- and 630E A+B- CT after 
96 h. 
 
Table S1.  Genomic and transcriptomic differences between 630, 630Δerm and 630E. 
SNPs, insertions (INS) and inversion (INV) are shown in this table as well as the corresponding RNAseq 
coverage. Changes between 630, 630Δerm and 630E are represented compared to the published 
genome of 630, the new 630 genome by Riedel et al. 22 and also the newly published genome of 
630Δerm 23. 
 
See attached excel file: S1_Table 
 
Table S2. Colonisation of hamsters with C. difficile strains. 
Colonisation of hamsters with 630E, 630E A+B- and 630E A+B- CT was confirmed by plating faecal 
and caecal samples on CDFA and by extraction genomic DNA and PCR of the toxin A and B genes.  
 
Strain given Colonisation 630 PCR tcdA tcdB Succumbed to CDI 
630E  Caecum + +  
630E Colonised to Day 18 Faecal + +  
630E Colonised to Day 15 Faecal + +  
630E  Caecum + + CDI 
630E  Caecum + + CDI 
630EA+B-  Caecum + - CDI 
630EA+B- Not colonised Faecal - -  
630EA+B- Not colonised Faecal - -  
630EA+B- Not colonised Faecal - -  
630EA+B- Not colonised Faecal - -  
39 
 
630EA+B-  Caecum + -  
630EA+B-  Caecum + - CDI 
630EA+B-  Caecum + -  
630EA+B- Colonised to Day 3 Faecal + -  
630EA+B-  Caecum + -  
630EA+B-  Caecum + -  
630E A+B- CT  Caecum + CT CDI 
630E A+B- CT  Caecum + CT CDI 
630E A+B- CT Colonised to Day 15 Faecal + CT  
630E A+B- CT Colonised to Day 18 Faecal + CT  
630E A+B- CT  Caecum + CT  
630E A+B- CT  Caecum + CT  
 
Table S3.  Transcriptomic differences between 630, 630Δerm and 630E. 
Differentially expressed (DE) genes, comparing RNAseq data from 6 h to 14 h and 24 h in 630, 
630Δerm and 630E. The genes are classed into cell factor, cell growth, cell wall, fermentation, 
membrane transport, amino acid metabolism, carbon metabolism, cofactor metabolism, lipid 
metabolism, nucleic acid metabolism, mobile elements, motility, operons, regulation, anaerobic 
respiration, secretion, sporulation, stress, translation, unknown and virulence factors. 
Downregulated genes are coloured in green and upregulated genes in red. 
 
See attached excel file: S3_Table 
 
Table S4.  Primers used in this study. 
 
Primer name Sequence (5’-3’) Explanation or SNP 
target (where 
applicable) 
topAMC1 GATGCACAACAGGCAAGAAGAGTGC To screen for 
chromosomal change 
topAMC2b CCCGATTGTAAAACAACTAGACCAATTATG To screen for 
chromosomal change 
flgBMC1b CTATCAAATACAGATGGAAGTTGTGGTG To screen for 
chromosomal change 
flgBMC2c CGAGCATATGATTCTAACGTAGATACATTGAATG To screen for 
chromosomal change 
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CD2667MC1 GTCACCTTATGAGTGAAGTTTGTAATAAATGTGG To screen for 
chromosomal change 
CD2667MC2b GCAAGAGCTGCTGCTGGAAGAC To screen for 
chromosomal change 
JRP3441 8 GTTACCAGGAATACAACCAGAC To test for interrupted 
tcdB 
JRP2839 8 CGGCCAGCCTCGCAGAGCAG To test for interrupted 
tcdB 
JRP3442 8 GCACTTGCTTGATCAAAGCTCC toxA specific PCR, 
positive for all strains 
(630E, 630E A+B-, 630E 
A+B-CT)   
JRP2342 8 CCGGAATTCGCTCTATTGGACTAGACCGTTG toxA specific PCR, 
positive for all strains 
(630E, 630E A+B-, 630E 
A+B-CT)   
Cdi-tcdB-F1 9 TGATAGTATAATGGCTGAAGCTAATGCAGATAATGG To test for tcdB 
ClosTron insertion 
Cdi-tcdB-R1 9 CTTGCATCGTCAAATGACC ATAAGCTAGCC To test for tcdB 
ClosTron insertion 
268934_F TGTCAAGTGAATTAGAAAGAAACCA 268934 
268934_R AAGTGAGCCGTGTTTTGAAAA 268934 
309208_F GCCAGTTGCCAAAAAGAGTC 309208 
309208_R GGCATAGCATCATTTAGTGTTTC 309208 
MCSNP11 CGGGAAAAACAGCTGCTTTTAGTATCCC 933139 
MCSNP12 CCTCTTGCTTGTAAATCTCCTACCAATTC 933139 
10000995_F GATGAAGAAGTTGTTTGGCAAT 1000995 
10000995_R CCTACTTGGCTACACCTTTTACA 1000995 
1391850_F TCTGTCATTTGGAAAGGATGAA 1391850 
1391850_R TCTGTACTTGCTTTTGATATACTTGGA 1391850 
Spo0A_F1 GGCATAGCTAAGGATGGAATTG 1413057 
Spo0A_R1 GGAGTAGAGGAAAAGTTGACACAA 1413057 
1480649_F GCTTCAACAAGAAGGAGCAAA 1480649 
1480649_R TGCTGGTGGTTGTGTAAAATG 1480649 
1607453_F TTGAAGGTGTAAACTCAGTTGTAGG 1607453 
1607453_R TCCAAATAAAAGTCTATGAAAATGAA 1607453 
1626977_F TGGTGGTAGCAAAAACGAAA 1626977 
1626977_R TGCCATTGAATTTGTTGCAG 1626977 
2044514_F CATACTAAATGAGGGGTAAAATAAAGA 2044514 
2044514_R TTTTTCTGCCTTTTCTCTTTGTG 2044514 
MCSNP1 GTTCTGTAATACCTTTTTCTTTAGCTATTTTAATTGC 2203033 
MCSNP2 GTTACCGATATTATAGGCAAAACTGCCC 2203033 
2209236_F CCATTAGTGAGTGATGATTTACTTCC 2209236 
2209236_R GCAAGTTTTGCTATTTCTCTTTCTT 2209236 
2320410_F GTCACTGGTAGGAATTAATCTAACG 2320410 
2320410_R TGCTTTCACAAATGCTTTCG 2320410 
MCSNP13 GAAAGATGAATTTCTATCCATCTTCATCAAATGTGG 2339506 
MCSNP14 GGGGCTGTTGACCTTGGACCC 2339506 
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MCSNP3 CCTTTGATGTCTAGTTAATTTCTTCACTTATTTTAAGC 2937176 
MCSNP4 GGAAAACCAGCAAAAGCTTGTATTATGATTCCC 2937176 
3005866_F AATATAATTCCCAACCTTCCAAA 3005866 
3005866_R    TTTGTTTGAAGATTAGTGGTGATTG 3005866 
MCSNP5 GTATATTTTTTCTCTAGCTTTATCTCCATCAGGG 3034953 
MCSNP6 GGAAAGGATAAACCAGGTATAGTGGC 3034953 
3079815_F CCCGCTTTTACTTCATCTCC 3079815 
3079815_R GCATCAGAGATTTTGATTGCTTT 3079815 
MCSNP7 CCTGCTACAAATTTTTTCTTTTCTGGC 3080703 
MCSNP8 CTGCTTATCTTTATAAAAAGTTTTATAAAATTGAATTACCTC 3080703 
MCSNP15 CTTCATATTGAGTGAAAGTCTGATTGAAGTTAGC 3422569 
MCSNP16 CTCAACCGTGTGCCGTTTTCCCG 3422569 
3526888_F CTCTTTCCTGCATTCCCAAG 3526888 
3526888_R TTGTTGAGCAGATATAAAATCCCA 3526888 
MCSNP17 CAATCTATTCAAAGATAAACTATAGTACTTCTTCTAC 3528736 
MCSNP18 CCTACTCCTTTAGGTGTGAGATGG 3528736 
3591103_F GGCACTAGCTGCTCCTAATAAA 3591103 
3591103_R   CCATATACCCCTATCCCTCCTT 3591103 
3686535_F TCTTCCAAGCTCTTACCTGTTTG 3686535 
3686535_R GCTCTGTCCAGTTAATTG 3686535 
3797112_F TGCTCCTGTAAATGCACCTG 3797112 
3797112_R CTGTAAAATACAAGTCACTCATTCCAA 3797112 
MCSNP19 CCGTTCCAGACTGTTCAATGCTCC 3951559 
MCSNP20 CCTAAGTAGTAGTTACTGGCAACAGCAC 3951559 
MCSNP9 GCACCCTTAATAACTTGACCAGTTAAAAAGG 4007463 
MCSNP10 CGCCCGAAGCCGATTATCTAACC 4007463 
4166495_F GCATCAAGTAAGTATTTATGCTCTTCA 4166495 
4166495_R TGAACTTGGATAATTACAAGCCATT 4166495 
 
